Evidence map›Paper›PMID 29594217›Full record

ArticleClinical and translational radiation oncology2017

Treatment constraints for single dose external beam preoperative partial breast irradiation in early-stage breast cancer.

Ramona K Charaghvandi, Sua Yoo, Bram van Asselen, Anna Rodrigues, Desirée H J G van den Bongard, Janet K Horton

Abstract read
In one paragraph

Article in Clinical and translational radiation oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ramona K CharaghvandiDepartment of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
Sua YooDepartment of Radiation Oncology, Duke Cancer Center, Durham, USA.
Bram van AsselenDepartment of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
Anna RodriguesDepartment of Radiation Oncology, Duke Cancer Center, Durham, USA.
Desirée H J G van den BongardDepartment of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
Janet K HortonDepartment of Radiation Oncology, Duke Cancer Center, Durham, USA.

Funding

Interdisciplinary Research Careers in Women's HealthK12HD043446 · NICHD · DUKE UNIVERSITY · PI AMUNDSEN, CINDY · 2002 to 2023
$9.6M
NICHD NIH HHS K12 HD043446
6 · The paper itself

Abstract

backgroundFollowing breast-conserving surgery and post-operative 3D-conformal accelerated partial breast irradiation (APBI), suboptimal cosmetic results have been reported. Preoperative radiation delivery to the intact tumor enables better target visualization and treatment volume reduction. Single dose preoperative APBI has the potential to improve toxicity profiles, reduce treatment burden and enable in vivo exploration of breast cancer radiogenomics. PURPOSE: Develop practical guidelines for single dose external beam preoperative APBI.

methodsRecommended dose constraints were derived from pooled dosimetry estimates from 2 clinical trials. In an American dose escalation trial, a uniform 15, 18 or 21 Gy dose has previously been evaluated for non-lobular cT1N0 or low/intermediate grade DCIS <2 cm in prone position (

resultsDosimetric data pooling enabled the development of practical guidelines for single dose preoperative APBI.

conclusionThe developed guidelines will allow further explorations in the promising field of single dose preoperative external beam APBI for breast cancer treatment.

Indexed as

Breast cancerGuidelinesPartial breastPreoperativeSingle dose

Identifiers

PMID29594217
PMCPMC5862640

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.